Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 4,035.00
-15.00 (-0.37%)
At close: Sep 22, 2026
| Market Cap | 44.55B -38.3% |
| Revenue (ttm) | 19.60B -16.0% |
| Net Income | 3.07B +45.2% |
| EPS | 272.90 +41.3% |
| Shares Out | 11.04M |
| PE Ratio | 14.79 |
| Forward PE | n/a |
| Dividend | 185.00 (4.59%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 607 |
| Open | 3,995.00 |
| Previous Close | 4,050.00 |
| Day's Range | 3,990.00 - 4,080.00 |
| 52-Week Range | 3,410.00 - 7,690.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |